Conserved Interferon-γ Signaling Drives Clinical Response to Immune Checkpoint Blockade Therapy in Melanoma is a research paper published in Cancer Cell (2020). On theSindex it has a DataRank of 0. It has been cited 389 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Radiological Society of North America
Grant: P01 CA244118
Radiological Society of North America
Grant: P30 CA016042
Radiological Society of North America
Grant: R35 CA197633
Boston Pharmaceuticals
Grant: 9402905
Boston Pharmaceuticals
Grant: 20170022275
Boston Pharmaceuticals
Grant: 20100111973
Boston Pharmaceuticals
Grant: 10279021
Boston Pharmaceuticals
Grant: 20160046716
Boston Pharmaceuticals
Grant: 20170008962
Boston Pharmaceuticals
Grant: 7250291
Boston Pharmaceuticals
Grant: 10106611
Boston Pharmaceuticals
Grant: 20160340407
Boston Pharmaceuticals
Grant: 20140004112
Boston Pharmaceuticals
Grant: 20170343552
Boston Pharmaceuticals
Grant: 20170248603
Merck
Grant: 15/612,657
Merck
Grant: PCT/US18/36052
Cancer Research Institute
Grant: CA233259
Cancer Research Institute
Grant: CA006973
GlaxoSmithKline
Grant: 3M
National Institutes of Health
Grant: T32-CA009120
National Cancer Institute
Grant: R01 CA142779
NCI NIH HHS
Grant: P30 CA006973
NCI NIH HHS
Grant: P30 CA008748
NCI NIH HHS
Grant: R01 CA121113
NCI NIH HHS
Grant: UG1 CA233259
NCI NIH HHS
Grant: T32 CA009120
National Institutes of Health
Grant: 1P01CA244118-01A1
Combination Therapies to Defeat Melanoma Resistance
National Institutes of Health
Grant: 5R01CA142779-03
B7-H1/PD-1 modulation in cancer therapy
National Institutes of Health
Grant: 2R35CA197633-08
Next Generation Cancer Immunotherapies to Defeat Melanoma
National Institutes of Health
Grant: 5R01CA121113-04
Large-scale Genetic Analyses of Gene Families in Colorectal Cancer
National Institutes of Health
Grant: 2P30CA008748-43
MOUSE GENETICS
National Institutes of Health
Grant: 3P30CA016042-35S3
Cancer Center Support Grant
National Institutes of Health
Grant: 3UG1CA233259-06S1
ECOG-ACRIN Thoracic Malignancies Integrated Translational Science Center
National Institutes of Health
Grant: 5T32CA009120-45
UCLA Tumor Immunology Institutional Traning Grant
AbbVie
Bayer Fund
Bloomberg~Kimmel Institute for Cancer Immunotherapy, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University
Eli Lilly and Company
Incyte
Melanoma Research Alliance
Tizona Therapeutics
Tower Cancer Research Foundation
Bristol-Myers Squibb
Clinical and Translational Science Institute, University of California, Los Angeles
Sanofi
Genentech
Roche
Swim Across America
American Association for Cancer Research
Astellas Pharma US
Dr. Miriam and Sheldon G. Adelson Medical Research Foundation
Kyowa Hakko Kirin
V Foundation for Cancer Research
EMD Serono
Johns Hopkins University
Mark Foundation For Cancer Research
Novartis
Parker Institute for Cancer Immunotherapy
American Society of Clinical Oncology
AstraZeneca
Entertainment Industry Foundation
Jounce Therapeutics
Commonwealth Foundation
LUNGevity Foundation
Takeda Pharmaceuticals U.S.A.
FWCI
17.41
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of Identification of cell subpopulations associated with disease phenotypes from scRNA-seq data using PACSI
Additional file 1 of Identification of cell subpopulations associated with disease phenotypes from scRNA-seq data using PACSI
Additional file 1 of ERK mediates interferon gamma-induced melanoma cell death
Additional file 1 of ERK mediates interferon gamma-induced melanoma cell death
Additional file 1 of Inhibiting interferon-γ induced cancer intrinsic TNFRSF14 elevation restrains the malignant progression of glioblastoma
Additional file 1 of Inhibiting interferon-γ induced cancer intrinsic TNFRSF14 elevation restrains the malignant progression of glioblastoma
Additional file 2 of ERK mediates interferon gamma-induced melanoma cell death
Additional file 2 of ERK mediates interferon gamma-induced melanoma cell death
Additional file 6 of Identification of cell subpopulations associated with disease phenotypes from scRNA-seq data using PACSI
Additional file 2 of Identification of cell subpopulations associated with disease phenotypes from scRNA-seq data using PACSI
Additional file 2 of Identification of cell subpopulations associated with disease phenotypes from scRNA-seq data using PACSI
Additional file 4 of Identification of cell subpopulations associated with disease phenotypes from scRNA-seq data using PACSI
Additional file 5 of Identification of cell subpopulations associated with disease phenotypes from scRNA-seq data using PACSI
Additional file 4 of Identification of cell subpopulations associated with disease phenotypes from scRNA-seq data using PACSI
Additional file 3 of Identification of cell subpopulations associated with disease phenotypes from scRNA-seq data using PACSI
Additional file 3 of Identification of cell subpopulations associated with disease phenotypes from scRNA-seq data using PACSI
Additional file 6 of Identification of cell subpopulations associated with disease phenotypes from scRNA-seq data using PACSI
Additional file 5 of Identification of cell subpopulations associated with disease phenotypes from scRNA-seq data using PACSI